v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (16,707,010) $ (11,930,847)
Adjustments to reconcile net loss to net cash used in operating activities:    
Credit loss provision 2,295
Depreciation 211,720 330,723
Change in straight-line rent receivable 10,496 (6,821)
Amortization of operating lease right-of-use asset 118,226 135,557
Stock-based compensation and service expense 1,179,761 1,106,634
Loss from equity method investments 8,589,822 41,863
Impairment of equipment held for sale 22,285
Impairment of equity method investment - Epicon 454,679
Amortization of debt issuance costs and debt discount 544,010 3,310,684
Conversion inducement expense 344,264
Change in fair market value of derivative liability (188,374) (600,749)
Gain on debts extinguishment (682,979)
Changes in operating assets and liabilities:    
Rent receivable (46,220) (43,765)
Security deposit 396 (416)
Deferred leasing costs 33,402 27,298
Prepaid expense and other assets 411 (45,996)
Accrued liabilities and other payables (16,601) 331,425
Accrued liabilities and other payables - related parties 106,458 79,898
Operating lease obligation (112,915) (141,556)
NET CASH USED IN OPERATING ACTIVITIES (6,504,718) (7,037,224)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (22,159) (1,749)
Additional investment in equity method investment (51,999)
Payments for equity interest purchase (8,999,722)
NET CASH USED IN INVESTING ACTIVITIES (22,159) (9,053,470)
CASH FLOWS FROM FINANCING ACTIVITIES    
Repayments of note payable - related party (390,000)
Proceeds from loan payable - related party 850,000 100,000
Repayments of loan payable - related party (410,000)
Proceeds from issuance of convertible debt and warrants 2,565,000 3,718,943
Payments of convertible debt issuance costs (327,200)
Repayments of convertible debt (300,000)
Proceeds from issuance of balloon promissory note 1,000,000 4,800,000
Payments of balloon promissory note issuance costs (64,436) (266,454)
Proceeds from equity offering 635,391 735,567
Disbursements for equity offering costs (19,132) (24,067)
Advance from sale of noncontrolling interest in subsidiary 485,714
Proceeds from issuance of convertible preferred stock 9,000,000
NET CASH PROVIDED BY FINANCING ACTIVITIES 4,825,337 17,263,989
EFFECT OF EXCHANGE RATE ON CASH (3,970) 10,077
NET (DECREASE) INCREASE IN CASH (1,705,510) 1,183,372
CASH - beginning of year 1,990,910 807,538
CASH - end of year 285,400 1,990,910
Cash paid for:    
Interest 718,753 176,000
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Common stock issued for accrued liabilities 164,871 30,000
Reclassification of advances for equity interest purchase to equity method investment 9,000,000
Series B Convertible Preferred Stock issued related to equity method investment 11,000,000
Accrued purchase price related to equity method investment 666,667
Warrants issued as convertible note payable finder’s fee 16,977
Warrants issued with convertible note payable recorded as debt discount 196,193 498,509
Bifurcated embedded conversion feature recorded as derivative liability and debt discount 2,782,569
Common stock issued as convertible note payable commitment fee 236,400
Deferred financing costs in accrued liabilities 202,892
Conversion of convertible note payable and accrued interest into common stock 4,072,958
Reclassification of derivative liability to equity 2,181,820
Related party loan and accrued interest settled in shares $ 2,888,593

Source

PDF HTML
ZIP